Latest Regulatory News

Cobalt Blue Holdings reveals promising engineering upgrades and exploration success at its Halls Creek Project, targeting enhanced margins and extended mine life through silver recovery, cobalt credits, and new copper discoveries.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

Havilah Resources has struck a binding deal with Heavy Rare Earths, granting earn-in rights to its Prospect Hill tin project with a $1.5 million exploration commitment over three years. The arrangement allows Havilah to focus on its copper assets while retaining significant upside exposure.

Brickworks Limited and Washington H. Soul Pattinson have unveiled plans to combine under a newly capitalised ASX-listed entity, Topco, aiming to simplify their complex cross-shareholding and unlock shareholder value. Shareholders are set to vote on the scheme in September, with the merger expected to enhance liquidity and deliver dividend accretion.

The Lederer Group has announced an off-market takeover offer for all stapled securities in the Elanor Commercial Property Fund at 70 cents each, representing a premium over recent trading prices. The bid comes amid governance concerns and a proposed overhaul of the fund’s management structure.

Unith Ltd has acknowledged a technical breach of its trading policy following a director's share purchase during a closed period, prompting a comprehensive review of its governance framework.

Papyrus Australia Ltd has announced a $262,000 capital raise through a share placement and unlisted options, aiming to strengthen its working capital and research efforts.

Syntara Limited’s trading suspension has been lifted as the company lodged its quarterly activity and cash flow reports for June 2025, reopening its shares to market activity.

X2M Connect Limited’s X2MO securities have been suspended from ASX trading due to non-compliance with listing rules, raising questions about the company’s regulatory standing and next steps.

Domain Holdings Australia announces a special fully franked dividend of 8.8 cents per share, contingent on shareholder and court approval of its acquisition by CoStar Group.

Rhythm Biosciences has advanced its ColoSTAT® diagnostic kits to final production validation, demonstrating consistent detection of colorectal cancer across all stages in a pivotal study. The company is gearing up for regulatory submission and commercial launch later this year.

InVert Graphite reports robust trench assay results from its Kumba deposit in Tanzania, revealing consistent high-grade graphite mineralisation over a 2km strike. The company is advancing drilling preparations amid a significant US move to impose anti-dumping duties on Chinese graphite imports.